Wire Stories
Summit Therapeutics Closes Deal with Akeso Inc. to In-License Breakthrough Innovative Bispecific Antibody
MENLO PARK, Calif.–(BUSINESS WIRE)–$SMMT–Summit Therapeutics Inc. (NASDAQ: SMMT) (�Summit,� �we,� or the �Company�) today announced that we have completed the closing of...